February 17, 2025
Show AI Summary
Money laundering probe into unauthorised diversion of codeine-based cough syrups prompts raids, asset seizures and tracing of suspects.
The Enforcement Directorate is investigating alleged money laundering from the unauthorised procurement, diversion and sale of codeine-based cough syrups through multiple commercial entities characterized as shell companies. Searches across jurisdictions yielded seizures of unexplained cash, jewellery and documentary and digital evidence, and located persons absconding in the related narcotics probe. The inquiry focuses on procurement and payment flows, alleged market diversion of product, cancelled licences by drug regulators, and transactional patterns forming the basis for asset-tracing and inter-agency referrals.